KLK3 and neoplasm: We used the American Joint Committee on Cancer (AJCC) 6th edition Tumor (T) stage, Gleason score, and prostate specific antigen (PSA) level at diagnosis to categorize patients into low‐ and intermediate‐risk groups based on NCCN definitions.1